Pressure Biosciences Inc
(PBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 315 | 518 | 609 | 560 | 165 |
| Cost of Goods | 171 | 258 | 287 | 226 | 26 |
| Gross Profit | 144 | 260 | 322 | 334 | 139 |
| Operating Expenses | 1,536 | 1,761 | 1,255 | 1,635 | 1,206 |
| Operating Income | -1,221 | -1,243 | -646 | -1,075 | -1,041 |
| Interest Expense | 2,926 | 3,330 | 3,526 | 4,668 | 2,843 |
| Other Income | 267 | -378 | -573 | -834 | -320 |
| Pre-tax Income | -3,880 | -4,951 | -4,745 | -6,578 | -4,204 |
| Net Income Continuous | -3,880 | -4,951 | -4,745 | -6,578 | -4,204 |
| Net Income | $-3,880 | $-4,951 | $-4,745 | $-6,578 | $-4,204 |
| EPS Basic Total Ops | -0.25 | -0.82 | -0.90 | -1.45 | -2.51 |
| EPS Basic Continuous Ops | -0.20 | -0.65 | -0.83 | -1.35 | -0.88 |
| EPS Diluted Total Ops | -0.25 | -0.82 | -0.90 | -1.45 | -2.51 |
| EPS Diluted Continuous Ops | -0.20 | -0.65 | -0.83 | -1.35 | -0.88 |
| EBITDA(a) | $236 | $184 | $1,126 | $1,118 | $959 |